PubMed · 2001 · 211 citations · 18 references
Life SciencesGeneticsOncologyGene ExpressionMolecular OncologyTranscriptional RegulationCancer EpigeneticsEpigenetic Regulation In CancerMalignant NeoplasmsMammary TumorsPromoter RegulationTumor Suppressor GenesBreast Cancer EpigeneticsMalignant Breast TumorsPromoter HypermethylationPromoter MethylationPromoter Methylation AnalysisTumor Suppressor Gene HypermethylationTumor Suppressor Gene MethylationWilms Tumor 1
We analyzed Wilms' tumor suppressor 1 (WT1) expression and its regulation by promoter methylation in a panel of normal breast epithelial samples and primary carcinomas. Contrary to previous reports, WT1 protein was strongly expressed in primary carcinomas (27 of 31 tumors) but not in normal breast epithelium (1 of 20 samples). Additionally, the WT1 promoter was methylated in 6 of 19 (32%) primary tumors, which nevertheless expressed WT1. The promoter is not methylated in normal epithelium. Thus, although tumor-specific methylation of WT1 is established in primary breast cancer at a low frequency, other transcriptional regulatory mechanisms appear to supercede its effects in these tumors. Our results demonstrate expression of WT1 in mammary neoplasia, and that WT1 may not have a tumor suppressor role in breast cancer.
18
Aberrant CpG-island methylation has non-random and tumour-type–specific patterns
J Costello, Michael C. Frühwald, Dominic J. Smiraglia et al. · Nature Genetics · 2000 · 1.4K citations
MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex
Huck‐Hui Ng, Yi Zhang, Brian Hendrich et al. · Nature Genetics · 1999 · 939 citations · Full text